Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution

Cryobiology

Volumn 62, Issue 2, 2011, Pages 100-106

  Johnson, L N ^a   Winter, K M ^a   Reid, S ^a   Hartkopf Theis, T ^a   Marks, D C ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Cryopreservation; Dimethyl sulfoxide; Platelet; Platelet additive solution; SSP+

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; DIMETHYL SULFOXIDE; PADGEM PROTEIN; THROMBOCYTE CONCENTRATE;

APOPTOSIS; ARTICLE; BLOOD BUFFY COAT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; FREEZE THAWING; IN VITRO STUDY; MEMBRANE RECONSTITUTION; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHELF LIFE; THROMBOCYTE AGGREGATION; THROMBOCYTE PRESERVATION;

BLOOD BUFFY COAT; BLOOD PLATELETS; BLOOD PRESERVATION; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; CYTOKINES; DIMETHYL SULFOXIDE; FREEZING; GLUCOSE; LACTIC ACID; P-SELECTIN; PLASMA; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; SOLUTIONS;

EID: 79952193373     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2011.01.003     Document Type: Article

References (47)

1. Albanyan A.-M., Harrison P., Murphy M.F. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7days. Transfusion 2009, 49:108-117.
2. Balduini C., Mazzucco M., Sinigaglia F., Grignani G., Bertolino G., Noris P., Pacchiarini L., Torti M., Salvaneschi L. Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. Haematologica 1993, 78:101-104.
3. Balint B., Paunovic D., Vucetic D., Vojvodic D., Petakov M., Trkuljic M., Stojanovic N. Controlled-rate versus uncontrolled-rate freezing as predictors for platelet cryopreservation efficacy. Transfusion 2006, 46:230-235.
4. Barnard M.R., MacGregor H., Ragno G., Pivacek L.E., Khuri S.F., Michelson A.D., Valeri C.R. Fresh, liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion 1999, 39:880-888.
5. Bertolini F., Murphy S. Biomedical excellence for safer transfusion working party of the international society of blood, a multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Transfusion 1996, 36:128-132.
6. Blumberg N., Gettings K.F., Turner C., Heal J.M., Phipps R.P. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006, 46:1813-1821.
7. Brown S.B., Clarke M.C.H., Magowan L., Sanderson H., Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. Journal of Biological Chemistry 2000, 275:5987-5996.
8. Cognasse F., Hamzeh-Cognasse H., Lafarge S., Acquart S., Chavarin P., Courbil R., Fabrigli P., Garraud O. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study. Transfusion 2009, 49:91-98.
9. Dijkstra-Tiekstra M.J., de Korte D., Pietersz R.N.I., Reesink H.W., van der Meer P.F., Verhoeven A.J. Comparison of various dimethyl sulphoxide-containing solutions for cryopreservation of leuco-reduced platelet concentrates. Vox Sanguinis 2003, 85:276-282.
10. Gao D.Y., Neff K., Xiao H.Y., Matsubayashi H., Cui X.D., Bonderman P., Bonderman D., Harvey K., McIntyre J.A., Critser J., Miraglia C.C., Reid T. Development of optimal techniques for cryopreservation of human platelets: I. Platelet activation during cold storage (at 22 and 8°C) and cryopreservation. Cryobiology 1999, 38:225-235.
11. Goodrich R.P., Li J., Pieters H., Crookes R., Roodt J., Heyns A.D.P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sanguinis 2006, 90:279-285.
12. Guide to the preparation, Use and Quality Assurance of Blood Components, Council of Europe Publishing, Strassbourg, France, 2008.
13. Guidelines for the Blood Transfusion Services in the UK, The Stationery Office, 2005.
14. Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfusion Medicine Reviews 2003, 17:209-215.
15. Gulliksson H., AuBuchon J.P., Cardigan R., van der Meer P.F., Murphy S., Prowse C., Richter E., Ringwald J., Smacchia C., Slichter S., de Wildt-Eggen J. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sanguinis 2003, 85:199-205.
16. Gulliksson H., Larsson S., Kumlien G., Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sanguinis 2000, 78:176-184.
17. Hartley P.S., Savill J., Brown S.B. The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets. Thrombosis and Haemostasis 2006, 95:100-106.
18. Hess J.R., Holcomb J.B. Transfusion practice in military trauma. Transfusion Medicine 2008, 18:143-150.
19. Hirayama J., Azuma H., Fujihara M., Homma C., Yamamoto S., Ikeda H. Storage of platelets in a novel additive solution (M-Sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007, 47:960-965.
20. Hodge G.L., Hodge S.J., Nairn J., Tippett E., Holmes M., Reynolds P.N. Poststorage leuko-depleted plasma inhibits T-cell proliferation and Th1 response in vitro: characterization of TGF[beta]-1 as an important immunomodulatory component in stored blood. Transplantation 2005, 80:95-101.
21. Holme S., Moron G., Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical excellence for safer transfusion working party of the international society of blood transfusion. Transfusion 1998, 38:31-40.
22. Holme S., Sweeney J.D., Sawyer S., Elfath M.D. The expression of P-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997, 37:12-17.
23. Hornsey V.S., McMillan L., Morrison A., Drummond O., MacGregor I.R., Prowse C.V. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion 2008, 48:2508-2514.
24. Khuri S., Healey N., MacGregor H., Barnard M., Szymanski I., Birjiniuk V., Michelson A., Gagnon D., Valeri C. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 1999, 117:172-183.
25. Landi E.P., Roveri E.G., Ozelo M.C., Annichino-Bizzacchi J.M., Origa A.F., de Carvalho Reis A.R., de Souza C.A., Marques J.F.C. Effects of high platelet concentration in collecting and freezing dry platelets concentrates. Transfusion and Apheresis Science 2004, 30:205-212.
26. Lee D.H., Blajchman M.A. Novel treatment modalities: new platelet preparations and substitutes. British Journal of Haematology 2001, 114:496-505.
27. Lee J.H., Kim J.T., Cho Y.G. Effect of nitric oxide on the cryopreservation of platelets. The Korean Journal of Laboratory Medicine 2008, 28:136-143.
28. Lelkens C.C.M., Koning J.G., de Kort B., Floot I.B.G., Noorman F. Experiences with frozen blood products in the Netherlands military. Transfusion and Apheresis Science 2006, 34:289-298.
29. Maurer-Spurej E., Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfusion Medicine Reviews 2007, 21:295-306.
30. Nie Y., de Pablo J.J., Palecek S.P. Platelet cryopreservation using a trehalose and phosphate formulation. Biotechnology and Bioengineering 2005, 92:79-90.
31. Owens M., Holme S., Heaton A., Sawyer S., Cardinali S. Post-transfusion recovery of function of 5-day stored platelet concentrates. British Journal of Haematology 1992, 80:539-544.
32. Pedrazzoli P., Noris P., Perotti C., Schiavo R., Ponchio L., Belletti S., Prada G.A.D., Balduini C.L., Salvaneschi L., Cuna G.R.D., Siena S. Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethyl sulphoxide in patients with severe thrombocytopenia: a pilot study. British Journal of Haematology 2000, 108:653-659.
33. Perrotta P.L., Perrotta C.L., Snyder E.L. Apoptotic activity in stored human platelets. Transfusion 2003, 43:526-535.
34. Ringwald J., Zimmermann R., Eckstein R. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfusion Medicine Reviews 2006, 20:158-164.
35. Rumjantseva V., Hoffmeister K.M. Novel and unexpected clearance mechanisms for cold platelets. Transfusion and Apheresis Science 2010, 42:63-70.
36. Schiffer C.A., Aisner J., Wiernik P.H. Clinical experience with transfusion of cryopreserved platelets. British Journal of Haematology 1976, 34:377-385.
37. Taylor M.A. Cryopreservation of platelets: an in-vitro comparison of four methods. Journal of Clinical Pathology 1981, 34:71-75.
38. Vadhan-Raj S., Kavanagh J.J., Freedman R.S., Folloder J., Currie L.M., Bueso-Ramos C., Verschraegen C.F., Narvios A.B., Connor J., Hoots W.K., Broemeling L.D., Lichtiger B. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Lancet 2002, 359:2145-2152.
39. Valeri C.R., Gina R., Shukri K. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80°C without postthaw processing. Transfusion 2005, 45:1890-1898.
40. Valeri C.R., Macgregor H., Ragno G. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension. Transfusion 2005, 45:596-603.
41. Valeri C.R., Rithy S., Joseph P.L., Gina R. Effect of WBC reduction and storage temperature on PLTs frozen with 6 percent DMSO for as long as 3 years. Transfusion 2003, 43:1162-1167.
42. van der Meer P.F. Platelet additive solutions: a future perspective. Transfusion Clinique et Biologique 2007, 14:522-525.
43. van Zanten G.H., Heijnen H.F.G., Wu Y., Schut-Hese K.M., Slootweg P.J., de Groot P.G., Sixma J.J., Nieuwland R. A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. Blood 1998, 91:2353-2359.
44. Verhoeven A.J., Verhaar R., Gouwerok E.G.W., de Korte D. The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005, 45:82-89.
45. Vetlesen A., Mirlashari M.R., Ezligini F., Kjeldsen-Kragh J. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007, 47:126-132.
46. Wakamoto S., Fujihara M., Kuzuma K., Sato S., Kato T., Naohara T., Kasai M., Sawada K.-I., Kobayashi R., Kudoh T., Ikebuchi K., Azuma H., Ikeda H. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003, 43:1038-1046.
47. Zhang J.G., Carter C.J., Culibrk B., Devine D.V., Levin E., Scammell K., Weiss S., Gyongyossy-Issa M.I.C. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008, 48:847-856.